Trial Profile
A Phase I study to evaluate the safety, tolerability and pharmacodynamics of inhaled Leukotriene B4 (LTB4) in healthy subjects and in chronically infected bronchiectasis patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Leukotriene B4 (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions
- Sponsors LTB4 AB
- 26 Nov 2014 New trial record